survey
regard
preval
import
five
german
state
veterinari
laboratori
cryptosporidium
diagnos
annual
faecal
sampl
either
submit
laboratori
taken
post
mortem
approxim
half
case
enteropathogen
detect
howev
laboratori
particip
questionnair
survey
routin
test
parasit
major
research
consid
cryptosporidiosi
minor
import
placebocontrol
field
studi
suckl
calv
treat
daili
cryptosporidiosi
either
sulfadimidin
halofuginon
halocur
intervet
week
treatment
oral
drench
start
onset
diarrhoea
herd
oocyst
excret
faecal
consist
health
statu
record
five
time
period
oocyst
excret
peak
day
placebo
group
onset
diarrhoea
period
preval
intens
excret
significantli
lower
halofuginonetr
group
compar
sulfadimidin
placebo
control
group
health
statu
diarrhoea
dehydr
declin
group
significantli
p
better
halofuginon
group
first
week
halofuginon
effect
p
reduc
oocyst
excret
improv
health
statu
treat
anim
sulfadimidin
effect
cryptosporidium
intestin
coccidium
cryptosporidium
known
caus
selflimit
diarrhoea
neonat
especi
calv
anim
infect
oocyst
environ
show
clinic
sign
diseas
pasti
wateri
diarrhoea
dehydr
within
day
infect
last
week
rommel
larg
number
oocyst
excret
togeth
strong
resist
exogen
stage
disinfect
blewett
fayer
et
al
turn
parasit
perpetu
threat
anim
health
product
affect
farm
parasit
found
worldwid
preval
young
calv
differ
european
countri
anon
lentz
et
al
see
chermett
boufassaouzrout
de
graaf
et
al
apart
veterinari
problem
cryptosporidium
caus
potenti
caus
zoonot
diseas
especi
immunocompromis
human
fayer
et
al
slifko
et
al
present
studi
evalu
preval
cryptosporidia
sampl
examin
veterinari
laboratori
estim
investig
regard
import
parasit
field
trial
efficaci
sulfadimidin
halofuginon
cryptosporidiosi
test
preliminari
survey
state
veterinari
laboratori
germani
particip
questionnair
regard
preval
import
bovin
cryptosporidiosi
questionnair
includ
question
routin
examin
procedur
sampl
young
calv
submit
laboratori
number
anim
examin
cryptosporidium
frequenc
well
statement
role
cryptosporidia
primari
secondari
pathogen
diagnost
result
five
state
veterinari
laboratori
germani
stade
lower
saxoni
stendal
saxonyanhalt
kassel
hessia
bonn
north
rhinewestfalia
aulendorf
badenwuerttemberg
examin
bovin
faec
carcass
evalu
evalu
includ
record
diarrhoea
andor
enter
calv
test
cryptosporidium
five
laboratori
routin
test
parasit
post
mortem
examin
calv
week
age
diarrhoea
faecal
sampl
calv
submit
post
mortem
examin
parasitolog
examin
base
stain
method
direct
smear
accord
hein
pohlenz
et
al
henriksen
pohlenz
semiquantit
estim
intens
one
case
sampl
examin
use
coproantigen
elisa
digestiv
elisa
kit
biox
belgium
addit
test
includ
flotat
faecal
sampl
eimeria
well
microbiolog
virolog
test
infecti
caus
enter
seven
dairi
herd
cow
north
rhinewestfalia
histori
persist
diarrhoea
presenc
cryptosporidium
includ
studi
calv
kept
separ
unit
straw
bed
first
week
life
except
one
farm
unit
disinfect
anim
fed
colostrum
first
day
life
receiv
commerci
milk
exchang
thereaft
day
roughag
offer
addit
cow
three
herd
vaccin
viral
diseas
rota
corona
parvoviru
e
coli
pilu
antigen
lactovac
hoechst
roussel
vet
gmbh
three
group
compris
calv
randomli
chosen
seven
herd
approxim
equal
number
anim
farm
group
treat
oral
day
anim
group
placebo
group
receiv
ml
tap
water
per
day
group
calv
sulfadimidin
group
treat
ml
sulfadimidin
g
sulfadimidinna
lohmann
anim
health
cuxhaven
group
anim
treat
daili
halocur
g
ml
solut
intervet
accord
weight
ie
kg
bodi
weight
correspond
mlanim
prepar
administ
farmer
receiv
three
colourcod
otherwis
unlabel
bottl
togeth
colourlabel
ml
plastic
syring
farmer
inform
content
respect
bottl
treatment
began
calv
age
day
start
sign
diarrhoea
calv
born
thereaft
includ
studi
treat
day
start
within
h
birth
studi
continu
calv
treat
one
prepar
calf
clinic
examin
five
time
studi
day
newborn
calv
first
second
day
life
receiv
colostrum
examin
randomli
assign
one
group
see
section
weak
sick
anim
diarrhoeic
exclud
record
data
includ
gener
perform
appetit
faecal
consist
normal
semiliquid
liquid
content
well
dehydr
day
studi
time
calv
examin
clinic
see
faecal
sampl
collect
examin
c
parvum
phase
contrast
microscopi
magnif
unstain
smear
naciri
person
commun
short
drop
satur
sugar
solut
mix
drop
faecal
materi
spread
microscop
slide
cover
cover
slip
method
use
semiquantit
evalu
oocyst
excret
number
oocyst
randomli
chosen
field
vison
determin
magnif
index
none
low
oocyst
medium
oocyst
high
oocyst
addit
sampl
taken
day
examin
c
parvum
rotaviru
coronaviru
e
coli
use
coproantigenelisa
digestiv
elisa
kit
biox
belgium
accord
manufactur
instruct
data
analys
spss
spss
inc
chicago
illinoi
use
spearman
rank
correl
coeffici
test
correl
two
observ
paramet
pearson
test
differ
result
observ
differ
day
mannwhitney
utest
differ
group
accord
preliminari
questionnair
laboratori
regularli
examin
calf
faec
presenc
c
parvum
wherea
eight
suspect
case
twenti
laboratori
describ
parasit
common
nine
found
rare
six
laboratori
consid
import
primari
pathogen
wherea
other
laboratori
thought
c
parvum
common
secondari
caus
diarrhoea
rest
thought
rare
laboratori
answer
part
questionnair
consid
preval
cryptosporidia
faecal
sampl
three
laboratori
thought
two
three
laboratori
result
routin
diagnost
test
describ
tabl
faecal
sampl
post
mortem
case
test
posit
c
parvum
case
respect
pathogen
detect
mix
infect
c
parvum
commonli
associ
rotaviru
follow
e
coli
combin
rare
kassel
bonn
small
number
sampl
examin
annual
preval
cryptosporidium
vari
faecal
sampl
post
mortem
examin
laboratori
report
annual
preval
faecal
sampl
post
mortem
sampl
fig
trial
finish
clinic
healthi
calv
anim
group
group
group
sold
end
trial
fourteen
calv
die
eight
diarrhoea
tabl
begin
trial
oocyst
detect
anim
group
group
calv
group
shed
c
parvum
oocyst
tabl
signific
differ
group
p
halofuginon
group
significantli
lower
extens
sulfadimidin
p
placebo
p
group
similarli
halofuginon
group
significantli
lower
p
extens
two
group
tabl
intens
oocyst
excret
preval
peak
significantli
p
lower
halofuginon
group
medium
high
number
oocyst
shed
compar
placebo
group
sulfadimidin
group
respect
fig
gener
perform
compar
three
group
least
calv
group
good
condit
follow
sampl
date
condit
declin
group
especi
fig
signific
differ
seen
p
comparison
halofuginon
group
averag
appetit
group
chang
littl
differ
group
insignific
shown
contrast
increas
preval
diarrhoea
declin
later
fig
differ
group
signific
halofuginon
versu
placebo
p
halofuginon
versu
placebo
p
halofuginon
versu
sulfadimidin
p
halofuginon
versu
placebo
p
blood
faec
preval
sampl
differ
group
maximum
preval
mucu
appear
time
sampl
irrespect
group
dehydr
show
similar
pattern
diarrhoea
fig
significantli
lower
rate
halofuginon
group
placebo
group
p
number
excret
diarrhoea
alway
significantli
lower
halofuginon
group
group
highest
preval
diarrhoea
amongst
oocystshed
anim
respect
compar
group
p
group
preval
highest
p
compar
group
fig
group
preval
diarrhoea
highest
excret
peak
declin
afterward
group
reach
peak
last
sampl
day
excret
declin
tabl
fig
halofuginon
group
highest
preval
calv
display
neither
oocyst
excret
diarrhoea
respect
compar
placebo
group
sulfadimidin
group
three
group
similar
preval
healthi
anim
group
group
group
signific
correl
oocyst
excret
diarrhoea
found
group
p
group
p
group
p
well
group
p
signific
correl
oocyst
excret
sever
diarrhoea
could
found
notabl
halofuginon
group
excret
show
diarrhoea
four
liquid
faec
sulfadimidin
group
placebo
group
excret
diarrhoeic
significantli
p
less
group
comparison
anim
differ
farm
show
half
diarrhoeic
anim
came
one
farm
also
account
coronavirusposit
calv
see
major
assign
halofuginon
group
anim
farm
exclud
differ
three
group
well
correl
excret
diarrhoea
group
statist
insignific
fig
preval
calv
excret
oocyst
diarrhoea
signific
correl
excret
diarrhoea
p
p
signific
differ
group
p
p
p
group
placebo
group
sulfadimidin
group
halofuginon
e
coli
could
detect
examin
date
sampl
virusposit
coronaviru
rotaviru
simultan
infect
detect
fig
accord
result
veterinari
laboratori
around
one
quarter
sampl
calv
either
faecal
sampl
submit
laboratori
sampl
taken
post
mortem
test
posit
c
parvum
oocyst
around
half
monoinfect
show
preval
parasit
probabl
underestimatedonli
laboratori
includ
parasit
routin
test
consid
common
investig
estim
preval
role
cryptosporidia
primari
caus
diarrhoea
acknowledg
investig
bia
sampl
submit
state
laboratori
allow
direct
comparison
field
investig
retrospect
evalu
howev
examin
field
sampl
differ
part
germani
show
preval
cryptosporidia
calv
age
month
rang
mostli
monoinfect
hein
boch
stein
et
al
fiedler
schulz
et
al
consid
fact
c
parvum
preval
calv
week
age
krogh
henriksen
schulz
et
al
de
graaf
et
al
age
group
probabl
consider
higher
preval
present
data
indic
although
cryptosporidia
acknowledg
primari
pathogen
pohlenz
et
al
stein
et
al
krogh
henriksen
de
graaf
et
al
veterinarian
seem
awar
preval
import
chang
group
size
mostli
due
death
first
half
trial
toward
end
sale
calv
diminish
group
especi
halofuginon
group
signific
number
anim
clinic
healthi
day
sale
accord
owner
sold
therefor
overal
perform
remain
calv
probabl
averag
especi
high
number
diarrhoeic
calv
group
could
explain
situat
addit
possibl
effect
coronaviru
infect
group
might
reduc
health
statu
anim
even
increas
excret
rate
cryptosporidium
oocyst
sinc
virolog
examin
done
time
definit
caus
phenomenon
determin
although
enteropathogen
present
low
preval
probabl
due
vaccin
cow
three
seven
herd
group
correl
c
parvum
diarrhoea
evid
first
week
also
observ
worker
stein
et
al
hein
et
al
krogh
henriksen
schulz
et
al
fayer
de
graaf
et
al
howev
correl
faecal
consist
excret
rate
seen
contrast
observ
schulz
et
al
studi
diarrhoea
rare
accompani
blood
mucu
faec
sign
tissu
destruct
alway
present
cryptosporidiosi
nagi
pohlenz
hein
et
al
krogh
henriksen
naciri
et
al
expect
diarrhoea
correl
gener
perform
anim
clinic
sign
dehydr
report
earlier
schulz
et
al
treatment
sulfadimidin
neither
improv
oocystshed
improv
clinic
perform
anim
compar
placebo
group
contrast
daili
applic
halocur
dose
mlanim
week
significantli
reduc
oocyst
excret
diarrhoea
experiment
condit
halofuginon
could
complet
prevent
parasit
shed
peeter
et
al
studi
metaphylact
applic
chosen
aim
reduc
clinic
sign
cryptosporidiosi
excret
oocyst
therapeut
applic
also
possibl
although
halofuginon
could
complet
prevent
infect
field
condit
effect
drug
current
avail
treatment
bovin
cryptosporidiosi
although
known
rel
toxic
requir
exact
dosag
applic
farmer
accord
instruct
save
studi
summari
cryptosporidia
preval
parasit
calv
germani
consid
import
caus
diarrhoea
treatment
recommend
reduc
diseas
contamin
environ
infect
oocyst
howev
contamin
environ
complet
prevent
current
avail
drug
therefor
emphasis
effect
longterm
control
parasit
achiev
integr
manag
includ
hygien
measur
regular
clean
disinfect
eg
neopredisan
chlorocresol
menno
chemi
norderstedt
germani
also
control
enteropathogen
separ
excret
econom
use
drug
combin
measur
mandatori
prevent
develop
resist
